Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Operating Expenses (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Operating Expenses for 16 consecutive years, with $152.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses fell 2.86% year-over-year to $152.1 million, compared with a TTM value of $620.2 million through Dec 2025, up 63.95%, and an annual FY2025 reading of $620.2 million, up 0.75% over the prior year.
  • Operating Expenses was $152.1 million for Q4 2025 at Orthofix Medical, down from $162.9 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $440.2 million in Q4 2023 and bottomed at $9.5 million in Q3 2023.
  • Average Operating Expenses over 5 years is $103.5 million, with a median of $55.6 million recorded in 2023.
  • The sharpest move saw Operating Expenses crashed 69.46% in 2023, then skyrocketed 1396.2% in 2025.
  • Year by year, Operating Expenses stood at $31.5 million in 2021, then skyrocketed by 748.86% to $267.4 million in 2022, then soared by 64.61% to $440.2 million in 2023, then tumbled by 64.43% to $156.6 million in 2024, then fell by 2.86% to $152.1 million in 2025.
  • Business Quant data shows Operating Expenses for OFIX at $152.1 million in Q4 2025, $162.9 million in Q3 2025, and $152.4 million in Q2 2025.